Position in JNJ
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$11,266,108
+$348,441 QoQ
Shares Held
44,360
-0.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
4.40%
of 13F equity value
Holder Rank
#1,039
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Towne Trust Company, N.A holds $24,022,988 across 11 Drug Manufacturers - General names. JNJ ranks #1 (46.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
44,360 | $11,266,108 | |
| 2 | AMGN |
Amgen Inc
|
19,650 | $7,115,658 | |
| 3 | MRK |
Merck & Co., Inc.
|
24,771 | $3,183,073 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
16,251 | $936,382 | |
| 5 | PFE |
Pfizer Inc
|
32,276 | $777,206 | |
| 6 | ABBV |
AbbVie Inc.
|
1,193 | $300,206 | |
| 7 | LLY |
ELI LILLY & Co
|
224 | $268,672 | |
| 8 | AZN |
Astrazeneca PLC
|
612 | $116,047 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,266,108 | 44,360 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $10,917,667 | 44,664 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $9,926,562 | 47,966 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $8,965,798 | 48,354 | Shares | Sole | 2025-10-08 | |
| 2025-06-30 | $7,460,462 | 48,841 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $8,168,449 | 49,255 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $7,152,905 | 49,460 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $8,183,867 | 50,499 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $7,397,741 | 50,614 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $7,735,173 | 48,898 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $7,572,735 | 48,314 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $7,661,341 | 49,190 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $8,216,081 | 49,638 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $7,675,290 | 49,518 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $8,500,927 | 48,123 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $8,190,542 | 50,138 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $8,960,171 | 50,477 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $9,186,894 | 51,836 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $8,941,486 | 52,268 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $8,110,529 | 50,220 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $8,379,994 | 50,868 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $8,261,545 | 50,268 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $7,673,375 | 48,757 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $7,184,501 | 48,257 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $6,870,618 | 48,856 | Shares | Sole | 2020-07-10 | |
| 2020-03-31 | $6,426,418 | 49,008 | Shares | Sole | 2020-04-15 | |
| No filing history on record for this holder in this stock. | ||||||